Madison, CT, United States of America

James J Elting




Average Co-Inventor Count = 3.2

ph-index = 14

Forward Citations = 589(Granted Patents)


Location History:

  • Oneonta, NY (US) (1991 - 1999)
  • Madison, CT (US) (1991 - 2020)

Company Filing History:


Years Active: 1991-2020

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: James J Elting: Pioneer in Angiogenesis Inhibition

Introduction

James J Elting is an esteemed inventor based in Madison, CT, with a remarkable portfolio of 26 patents. His innovations focus primarily on methods and compounds that address critical medical challenges, particularly those related to angiogenesis.

Latest Patents

Among his latest contributions to the field are patents for aryl ureas with angiogenesis inhibiting activity. These inventions detail methods for utilizing aryl ureas to treat diseases that involve the VEGF-induced signal transduction pathway, which is characterized by abnormal angiogenesis or hyperpermeability processes. The dual focus on both the treatment of these diseases and the specific molecular frameworks demonstrates his innovative approach to modern medical challenges.

Career Highlights

Throughout his career, Elting has worked with influential companies, including Bayer Corporation, where he furthered his research and development efforts in medicinal chemistry. His extensive work has played a crucial role in advancing therapeutic methodologies that target complex biological processes.

Collaborations

James Elting's collaborative efforts with fellow researchers, such as Thomas R Barnett and W E Mikhail, have been significant. These partnerships emphasize the importance of teamwork in scientific advancements and have enabled the proliferation of knowledge and innovation in the field.

Conclusion

James J Elting stands out as a key figure in the realm of innovation, particularly in the development of therapies aimed at regulating angiogenesis. His contributions continue to influence medical research and offer hope for improved treatments for diseases associated with vascular abnormalities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…